Age (years), median (IQR) |
44 (44-50) |
Male, n (%) |
110 (79.1%) |
Ethnicity, n (%) |
|
White |
64 (46.0%) |
Black |
61 (43.9%) |
Hispanic |
13 (9.4%) |
Other |
1 (0.7%) |
Comorbidity, n (%) |
|
Incidental |
88 (63.3%) |
Contributing |
35 (25.2%) |
Confounding |
16 (11.5%) |
Years of education, median (IQR) |
13.0 (12.0-15.0) |
Weight (kg), median (IQR) |
77.7 (70.5-87.8) |
Duration of HIV-infection (years), median (IQR) |
12.2 (6.3-15.8) |
Current CD4+ (cells/μL), median (IQR) |
540 (353-698) |
CD4+:CD8+ cell count ratio, median (IQR) |
0.60 (0.42-0.91) |
Nadir CD4+ (cells/μL), median (IQR) |
121 (20-237) |
Duration of antiretroviral therapy (years), median (IQR) |
6.3 (2.6-9.4) |
Plasma HIV RNA <50 copies/mL, n (%) |
139 (100%) |
Prior clinical AIDS, n (%) |
55 (39.6%) |